MDM2 and acute lymphoblastic leukemia: Nutlin-3a, an antagonist of MDM2, was reported to be able induce apoptosis in T-ALL cells with wild-type p53.48 These reports further support the notion that targeting USP7 is helpful in the treatment of T-ALL.